An International Study on Pediatric Patients With Rare Tumors.

ConditionsParaganglioma/ Phaeochromocytoma Melanoma and Other Malignant Neoplasms of Skin Gastrointestinal Stromal Tumor (GIST)Adrenocortical Tumor Pancreatic Tumors Esthesioneuroblastoma, Olfactory Mesothelioma Nasopharyngeal Carcinoma (NPC)NUT Carcinoma Pleuropulmonary Blastoma Salivary Gland Tumors Thymic Tumors Thyroid Carcinoma Appendiceal Cancers

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age0-18

SponsorAzienda Ospedaliera di Padova

About this trial

The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.

Eligibility criteria

Qualifiers

Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.

Written informed consent from the patient and/or the parent/legal guardian

Disqualifiers

Absence of Written informed consent from the patient and/or the parent/legal guardian

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Azienda Ospedaliera di Padova

Lead sponsor

St. Anna Children's Hospital, Vienna

Collaborator

Children's Hospital Zagreb

Collaborator

Centre Hospitalier Universitaire de La Réunion, FRANCE

Collaborator

Klinikum Dortmund

Collaborator

University Children's Hospital Tuebingen

Collaborator

Hellenic Oncology Research Group

Collaborator

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Collaborator

Kaplan Medical Center, Rehovot, Israel

Collaborator

Vilnius University Hospital Santaros Klinikos

Collaborator

University of Skopje

Collaborator

Gdansk Medical University (Poland)

Collaborator

Centro Hospitalar do Porto

Collaborator

Bucharest Emergency Hospital

Collaborator

Institute for Oncology and Radiology Serbia, Belgrade

Collaborator

University Hospital Bratislava

Collaborator

University Medical Centre Ljubljana

Collaborator

University of Bilbao

Collaborator

Göteborg University

Collaborator

University Hospital, Paris

Collaborator

Source ClinicalTrials.gov